NUZ 0.00% 19.0¢ neurizon therapeutics limited

Ann: Positive Interim Study Results from OLE Study in ALS, page-47

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 8,965 Posts.
    lightbulb Created with Sketch. 1750
    So let's address the other issue, that being the rejection of PAA's grant application.
    If my memory serves me correctly, FightMND asked PharmAust to submit an application for them to then reject the application seems strange.
    Most of the patients, 9 out of the 10 being treated under the Extension trial being done by Calvary Health under Susan Mathers, who it appears to have a great working relationship with FightMND one would think that this would have meant PAA had a shoe in to gain the grant.
    The results from the phase one look impressive
    So why no grant
 
watchlist Created with Sketch. Add NUZ (ASX) to my watchlist
(20min delay)
Last
19.0¢
Change
0.000(0.00%)
Mkt cap ! $93.42M
Open High Low Value Volume
19.5¢ 19.5¢ 19.0¢ $31.22K 164.2K

Buyers (Bids)

No. Vol. Price($)
7 362647 18.5¢
 

Sellers (Offers)

Price($) Vol. No.
19.0¢ 66191 2
View Market Depth
Last trade - 14.37pm 05/11/2024 (20 minute delay) ?
NUZ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.